Shaban Athuman
/
VPM News
Almost 40% of the county’s 2024 homicides were from instances of IPV.
Spotlight on VPM Original Content
RVA's Got Issues
VPM 60th Anniversary
Virginia News
NPR News
Virginia News
-
Commonwealth schools receive $2.4B, collectively, from the feds each year. -
The school's principal is recovering from life-threatening injuries.
-
Much of the talk surrounded federal funding uncertainties.
-
The local nonprofit provides various social services to residents.
-
Public meeting highlights in Central Virginia for the week beginning March 17.
-
Take a look at this week's top VPM News stories.
NPR News
-
ESPN says its long-anticipated subscription plan will cost $29.99 a month. An analyst says that, combined with subscriptions to other stream services, could drive the cost up to the price of cable packages.
-
The rapper's Instagram account says his lungs collapsed after he was stabbed 14 times, but he is "in good spirits." Lanez is serving a 10-year sentence for shooting Megan Thee Stallion in 2020.
-
This year's $500,000 World Food Prize, for advances in agriculture and nutrition, goes to Mariangela Hungria, who boosted Brazil's farming revolution, turning the country into a soybean superpower.
-
The agency is taking steps to remove prescription fluoride treatments that children swallow.
-
The updated dress code prohibits nudity on the Red Carpet and in other areas of the festival. The new rules surprised one jury member, who had to make a last-minute outfit change.
Arts & Culture
- Tara Roberts helps scuba divers uncover slave shipwrecks
- New Burying Ground honors enslaved labor at University of Richmond
- Museums, libraries and cultural groups grapple with federal humanities cuts
- ‘Idleness and boredom’: Virginia juvenile justice system strained by staffing shortages
Listen to VPM
- VPM Daily Newscast: Richmond City Council finalizes $3 billion FY26 budget
- Guest conductor Michael Repper leads the Richmond Symphony in Berlioz's Symphonie Fantastique
- VPM Daily Newscast: ‘Catalyst’ UVA Manning Institute for Biotechnology
- Interview: Keep finds the new normal